Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Flavors and Fragrances Market, Global, 2025-2032" report has been added to ResearchAndMarkets.com's offering.The flavors and fragrances market...
-
SAN DIEGO and SUZHOU, China, April 14, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and...
-
OSS, The Netherlands, April 14, 2026 (GLOBE NEWSWIRE) -- Trained Therapeutix Discovery, a biotechnology company founded by the Jean Boulle Group and the Heritage Group, today announced that its...
-
BOSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human,...
-
Western blotting market grows with rising disease diagnostics demand, and automation, driven by research expansion and protein analysis needs.
-
Company Announcement Net sales of DARZALEX® in the first quarter of 2026 totaled USD 3,964 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Difficult Conversations and Influence in Regulated Environments (Apr 27, 2026)" training has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Unique Device Identification (UDI) and Labelling for Medical Device Manufacturers (June 8, 2026)" training has been added to ResearchAndMarkets.com's...
-
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by...